Loading...

Co-Diagnostics, Inc.

CODX•NASDAQ
Healthcare
Medical - Devices
$1.97
$0.60(43.80%)
U.S. Market opens in 9h 33m

Co-Diagnostics, Inc. (CODX) Stock Overview

Explore Co-Diagnostics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.2M
P/E Ratio-0.10
EPS (TTM)$-32.26
ROE-1.65%
Fundamental Analysis

AI Price Forecasts

1 Month$2.30
3 Months$2.65
1 Year Target$1.61

CODX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Co-Diagnostics, Inc. (CODX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.61.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.10 and a market capitalization of 2.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
43.80%
5-Day Change
21.60%
1-Month Change
26.28%
3-Month Change
-19.59%
6-Month Change
-80.80%
Year-to-Date (YTD) Change
-61.14%
1-Year Change
-76.96%
3-Year Change
-95.24%
5-Year Change
-99.23%
All-Time (Max) Change
-98.87%

Contact Information

https://co-dx.com
801 438 1036
2401 S. Foothill Dr., Salt Lake City, UT, 84109

Company Facts

132 Employees
IPO DateJul 12, 2017
CountryUS
Actively Trading

Frequently Asked Questions